Journal Basic Info

  • Impact Factor: 0.285**
  • H-Index: 6
  • ISSN: 2638-4558
  • DOI: 10.25107/2638-4558
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Lung Cancer
  •  Radiology Cases
  •  Genetics
  •  Biochemistry and Biostatistics
  •  Cardiac Surgery
  •  Epilepsy and Seizures
  •  Mental Health
  •  Chemotherapy

Abstract

Citation: Clin Case Rep Int. 2020;4(1):1157.DOI: 10.25107/2638-4558.1157

Clinical Efficacy and Safety of Edaravone a New Molecule as a Ray of Hope for Motor Neuron Disease (An Incurable Illness) a Mini Review

Omar Farooq and Neha Sharma

Department of Medicine, GMC Srinagar, India

*Correspondance to: Omar Farooq 

 PDF  Full Text Mini Review | Open Access

Abstract:

The etiology of Amyotrophic Lateral Sclerosis (ALS) is unknown. Oxidative stress may be one of the major mechanisms involved. In vitro and in vivo data of edaravone suggest that it may possess broad free radical scavenging activity and protect neurons, glia, and vascular endothelial cells against oxidative stress. This paper describes and reviews data pertinent to the potential mechanism of action of edaravone, and reviews the development history of edaravone for the treatment of ALS.

Keywords:

Cite the Article:

Farooq O, Sharma N. Clinical Efficacy and Safety of Edaravone a New Molecule as a Ray of Hope for Motor Neuron Disease (An Incurable Illness) a Mini Review. Clin Case Rep Int. 2020; 4: 1157.

Search Our Journal

Journal Indexed In

Articles with Grants

Central Nervous System Infections Associated with the SARS-CoV-2 Virus
 Abstract  PDF  Full Text
Environmental Risk Factors Contributing to the Transmission of COVID-19 in Zambia: A Cross-Sectional Study in Lusaka District
 Abstract  PDF  Full Text
View More...